HC Wainwright reiterates Buy on Pharming, lifts $37 target
HC Wainwright & Co. reiterated a Buy rating on Pharming with a $37.00 price target, implying upside of 3,736.6% from the Sep 22 close of $0.96.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.